Table 1 Details of trials included in IVC treatment based on ICRB grading
Authors | Mean follow -up (months) | Globe salvage in different group eyes (%) | Overall Success Rate (%) | Second Tumor Rate (%) | Metastasis Rate (%) | Recurrence Rate (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
A (n = 31) | B (n = 142) | C (n = 23) | D (n = 458) | E (n = 106) | ||||||
Shields2006 | NA | 100.0(23/23) | 92.7(89/96) | 90.5(19/21) | 46.8(51/109) | NA | NA | NA | NA | NA |
Shin2010 | 53.3 | 100.0(8/8) | 71.4(10/14) | NA | 35.7(15/42) | 100.0(1/1) | 52.3(34/65) | NA | NA | NA |
Kaliki2011 | 66.0 | NA | NA | NA | NA | NA | NA | 0.0(0/52) | 0.0(0/52) | 7.7 (4/52) |
Turaka2011 | 80.0 | NA | NA | NA | NA | NA | NA | 3.8(6/156) | NA | NA |
Berry2013 | 45.4 | NA | NA | NA | 47.3(26/55) | NA | NA | 0.0(0/55) | 0.0(0/55) | 53.7 (29/55) |
Cohen2009 | 30.0 | NA | NA | NA | 61.1(11/18) | NA | NA | 0.0(0/18) | NA | NA |
Berry2017(1) | 86.3 | NA | NA | NA | 70.6(72/102) | 24.3(9/37) | 58.3(81/139) | NA | 0.7(1/139) | 0.7(1/139)- |
Fabian2017 | 64.4 | NA | NA | NA | 62.5(40/64) | NA | NA | NA | 0.0(0/64) | NA |
Friedman2017 | 24.0 | NA | 64.0(16/25) | NA | NA | NA | NA | NA | 0.0(0/25) | NA |
Shields2009 | 24.0 | NA | NA | NA | NA | 59.1(39/66) | NA | 1.6 (1/64) | NA | NA |
Yousef2017 | NA | NA | 100.0(7/7) | 100.0(2/2) | 75.0(12/16) | 0.0(0/2) | 83.3(25/30) | 0.0(0/30) | NA | NA |
Berry2017(2) | 33.0 | NA | NA | NA | 48.1(25/52) | NA | NA | NA | NA | 9.6 (5/52) |
Munier2017 | 105.3 | NA | NA | NA | NA | NA | NA | NA | NA | 52.2 (12/23) |